Welcome to Crash Course, a podcast about business, political, and social disruption and what we can learn from it.

I'm Tim O'Brien. Every week on Crash Course, I'm going to bring listeners directly into the arenas where epic upheavals occur and

I'm going to explore the lessons we can learn when creativity and ambition collide

with competition and power.

Listen to Crash Course every Tuesday on the IHeartRadio app, Apple Podcasts,

or wherever you get your podcasts.

Broadcasting live to New York,

to New York, Bloomberg 1130, to Washington, D.C.

Bloomberg 991, to Boston, Bloomberg 1200, to San Francisco, Bloomberg 960, to the country,

Sirius XM Channel 119, and around the globe, the Bloomberg Radio Plus

Ab at Bloomberg.com. This is Bloomberg surveillance. Good morning it is... at on vacation we can't tell you where he is but the hint we were giving out yesterday

is that they drive on the left hand side so that's three clues we'll call up with a

new one today for you and as the great where is Tom Keene search continues.

Tom is missing a lot this morning and if you haven't been with us for the last half hour

you have missed a lot. Abbott going to to buy St Jude Medical, this is a $25 billion deal, cash and shares.

AbbVie is going to acquire the cancer drug makers, STEM centrics.

That one's a $ 5.8 billion dollar deal also

cash in shares another 4 billion at play depending on what they call certain

regulatory issues and Ford out with a record profit and earnings of $0.68.

A share of the forecast was for $0.48.

So a major beat for the Dearborn folks and we are also watching Deutsche Bank this

morning surprised profit in the first quarter legal expenses drop trading

...